196 related articles for article (PubMed ID: 30035812)
1. Biocompatibility of mineral trioxide aggregate flow and biodentine.
Mondelli JAS; Hoshino RA; Weckwerth PH; Cerri PS; Leonardo RT; Guerreiro-Tanomaru JM; Tanomaru-Filho M; da Silva GF
Int Endod J; 2019 Feb; 52(2):193-200. PubMed ID: 30035812
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility evaluation of biodentine in subcutaneous tissue of rats.
Mori GG; Teixeira LM; de Oliveira DL; Jacomini LM; da Silva SR
J Endod; 2014 Sep; 40(9):1485-8. PubMed ID: 25146039
[TBL] [Abstract][Full Text] [Related]
3. Biodentine and mineral trioxide aggregate induce similar cellular responses in a fibroblast cell line.
Corral Nuñez CM; Bosomworth HJ; Field C; Whitworth JM; Valentine RA
J Endod; 2014 Mar; 40(3):406-11. PubMed ID: 24565661
[TBL] [Abstract][Full Text] [Related]
4. Mast cells and immunoexpression of FGF-1 and Ki-67 in rat subcutaneous tissue following the implantation of Biodentine and MTA Angelus.
da Fonseca TS; Silva GF; Guerreiro-Tanomaru JM; Sasso-Cerri E; Tanomaru-Filho M; Cerri PS
Int Endod J; 2019 Jan; 52(1):54-67. PubMed ID: 29975794
[TBL] [Abstract][Full Text] [Related]
5. Reactions of connective tissue to amalgam, intermediate restorative material, mineral trioxide aggregate, and mineral trioxide aggregate mixed with chlorhexidine.
Sumer M; Muglali M; Bodrumlu E; Guvenc T
J Endod; 2006 Nov; 32(11):1094-6. PubMed ID: 17055915
[TBL] [Abstract][Full Text] [Related]
6. Cell Viability and Tissue Reaction of NeoMTA Plus: An In Vitro and In Vivo Study.
Pinheiro LS; Iglesias JE; Boijink D; Mestieri LB; Poli Kopper PM; Figueiredo JAP; Grecca FS
J Endod; 2018 Jul; 44(7):1140-1145. PubMed ID: 29866406
[TBL] [Abstract][Full Text] [Related]
7. Effects of calcium silicate endodontic cements on biocompatibility and mineralization-inducing potentials in human dental pulp cells.
Chang SW; Lee SY; Ann HJ; Kum KY; Kim EC
J Endod; 2014 Aug; 40(8):1194-200. PubMed ID: 25069932
[TBL] [Abstract][Full Text] [Related]
8. Spheroid model study comparing the biocompatibility of Biodentine and MTA.
Pérard M; Le Clerc J; Watrin T; Meary F; Pérez F; Tricot-Doleux S; Pellen-Mussi P
J Mater Sci Mater Med; 2013 Jun; 24(6):1527-34. PubMed ID: 23515903
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility and biomineralization assessment of mineral trioxide aggregate flow.
Bueno CRE; Vasques AMV; Cury MTS; Sivieri-Araújo G; Jacinto RC; Gomes-Filho JE; Cintra LTA; Dezan-Júnior E
Clin Oral Investig; 2019 Jan; 23(1):169-177. PubMed ID: 29572687
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility of accelerated mineral trioxide aggregate in a rat model.
McNamara RP; Henry MA; Schindler WG; Hargreaves KM
J Endod; 2010 Nov; 36(11):1851-5. PubMed ID: 20951299
[TBL] [Abstract][Full Text] [Related]
11. Tissue reactions to a new mineral trioxide aggregate-containing endodontic sealer.
Tavares CO; Böttcher DE; Assmann E; Kopper PM; de Figueiredo JA; Grecca FS; Scarparo RK
J Endod; 2013 May; 39(5):653-7. PubMed ID: 23611385
[TBL] [Abstract][Full Text] [Related]
12. Reactions of Subcutaneous Connective Tissue to Mineral Trioxide Aggregate, Biodentine®, and a Newly Developed BioACTIVE Base/Liner.
Karabulut B; Dönmez N; Göret CC; Ataş C; Kuzu Ö
Scanning; 2020; 2020():6570159. PubMed ID: 32518612
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and bioactivity of various pulpotomy materials on stem cells from human exfoliated primary teeth.
Collado-González M; García-Bernal D; Oñate-Sánchez RE; Ortolani-Seltenerich PS; Álvarez-Muro T; Lozano A; Forner L; Llena C; Moraleda JM; Rodríguez-Lozano FJ
Int Endod J; 2017 Dec; 50 Suppl 2():e19-e30. PubMed ID: 28169432
[TBL] [Abstract][Full Text] [Related]
14. Odontogenic effect of a fast-setting pozzolan-based pulp capping material.
Park SJ; Heo SM; Hong SO; Hwang YC; Lee KW; Min KS
J Endod; 2014 Aug; 40(8):1124-31. PubMed ID: 25069919
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Evaluation of ProRoot MTA, Biodentine, and MM-MTA on Human Alveolar Bone Marrow Stem Cells in Terms of Biocompatibility and Mineralization.
Margunato S; Taşlı PN; Aydın S; Karapınar Kazandağ M; Şahin F
J Endod; 2015 Oct; 41(10):1646-52. PubMed ID: 26410417
[TBL] [Abstract][Full Text] [Related]
16. Cytocompatibility of Biodentine using a three-dimensional cell culture model.
Silva EJ; Senna PM; De-Deus G; Zaia AA
Int Endod J; 2016 Jun; 49(6):574-80. PubMed ID: 26100656
[TBL] [Abstract][Full Text] [Related]
17. Hypertension affects the biocompatibility and biomineralization of MTA, High-plasticity MTA, and Biodentine®.
Cosme-Silva L; Dal-Fabbro R; Gonçalves LO; Prado ASD; Plazza FA; Viola NV; Cintra LTA; Gomes Filho JE
Braz Oral Res; 2019 Jul; 33():e060. PubMed ID: 31365705
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the sealing abilities between Biodentine and MTA as root-end filling materials and their effects on bone healing in dogs after periradicular surgery.
Tang JJ; Shen ZS; Qin W; Lin Z
J Appl Oral Sci; 2019; 27():e20180693. PubMed ID: 31596370
[TBL] [Abstract][Full Text] [Related]
19. Reaction of rat subcutaneous tissue to mineral trioxide aggregate and Portland cement: a secondary level biocompatibility test.
Karanth P; Manjunath MK; ; Kuriakose ES
J Indian Soc Pedod Prev Dent; 2013; 31(2):74-81. PubMed ID: 23886716
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity, Biocompatibility, and Biomineralization of the New High-plasticity MTA Material.
Cintra LTA; Benetti F; de Azevedo Queiroz ÍO; de Araújo Lopes JM; Penha de Oliveira SH; Sivieri Araújo G; Gomes-Filho JE
J Endod; 2017 May; 43(5):774-778. PubMed ID: 28320539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
